Advisor Group Holdings, Inc. Biotechnology

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	17	Q4 2024 Added 7,352.94%
GNFT Genfit S.A.	$190M	$0 0.0% of portfolio	225	Q2 2025 New
IMAB I Mab	$391M	$0 0.0% of portfolio	30	Q2 2025 New
ITOS I Teos Therapeutics, Inc.	$361M	$0 0.0% of portfolio	56	Q2 2025 Reduced 92.18%
LTRN Lantern Pharma Inc.	$39.3M	$0 0.0% of portfolio	215	Q2 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$260M	$0 0.0% of portfolio	742	Q2 2025 Reduced 21.23%
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	277	Q2 2025 Reduced 64.58%
TARA Protara Therapeutics, Inc.	$52.3M	$0 0.0% of portfolio	100	Q1 2025 New
ENTA Enanta Pharmaceuticals Inc	$224M	$0 0.0% of portfolio	38	Q2 2025 Added 245.45%
KROS Keros Therapeutics, Inc.	$401M	$0 0.0% of portfolio	74	Q2 2025 New
BCAB Bio Atla, Inc.	$22.5M	$0 0.0% of portfolio	500	Q2 2025 Reduced 50.0%
ELEV Elevation Oncology, Inc.	$8.39M	$0 0.0% of portfolio	2,000	Q2 2024 Reduced 33.33%
BCYC Bicycle Therapeutics PLC	$198M	$0 0.0% of portfolio	18	Q2 2025 Reduced 97.63%
YMAB Y M Abs Therapeutics, Inc.	$376M	$0 0.0% of portfolio	4	Q2 2025 New
TVTX Travere Therapeutics, Inc.	$2.19B	$0 0.0% of portfolio	53	Q2 2025 Added 130.43%
PDSB Pds Biotechnology Corp	$25.6M	$0 0.0% of portfolio	517	Q2 2025 Reduced 90.63%
ACIU Ac Immune Sa	$279M	$0 0.0% of portfolio	251	Q2 2025 New
MRSN Mersana Therapeutics, Inc.	$871M	$0 0.0% of portfolio	2,598	Q2 2025 Reduced 24.3%
GLSI Greenwich Life Sciences, Inc.	$105M	$0 0.0% of portfolio	5	Q2 2025 New
TERN Terns Pharmaceuticals, Inc.	$660M	$0 0.0% of portfolio	10	Q2 2025 New
ANIX Anixa Biosciences Inc	$120M	$0 0.0% of portfolio	50	Q2 2025 Reduced 84.57%
FENC Fennec Pharmaceuticals Inc.	$209M	$0 0.0% of portfolio	94	Q2 2025 Reduced 37.33%
SPRO Spero Therapeutics, Inc.	$82.4M	$0 0.0% of portfolio	290	Q2 2025 New
TSHA Taysha Gene Therapies, Inc.	$209M	$0 0.0% of portfolio	134	Q3 2023 New
RLMD Relmada Therapeutics, Inc.	$74.1M	$0 0.0% of portfolio	5	Q4 2024 Added 540.0%
ANTX An2 Therapeutics, Inc.	$22.1M	$0 0.0% of portfolio	300	Q4 2023 Added 50.0%
DSGN Design Therapeutics, Inc.	$348M	$0 0.0% of portfolio	10	Q2 2025 Reduced 79.59%
NKTX Nkarta, Inc.	$94.4M	$0 0.0% of portfolio	180	Q2 2025 Reduced 76.92%
VTYX Ventyx Biosciences, Inc.	$457M	$0 0.0% of portfolio	61	Q2 2025 New
NAUT Nautilus Biotechnology, Inc.	$214M	$0 0.0% of portfolio	715	Q2 2025 Added 7,050.0%
IGMS Igm Biosciences, Inc.	$36.8M	$0 0.0% of portfolio	400	Q2 2025 Added 900.0%
FULC Fulcrum Therapeutics, Inc.	$442M	$0 0.0% of portfolio	90	Q2 2025 New
ORIC Oric Pharmaceuticals, Inc.	$493M	$0 0.0% of portfolio	20	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.